Ainos, Inc. (AIMD)
NASDAQ: AIMD · Real-Time Price · USD
0.620
-0.010 (-1.56%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ainos Employees
Ainos had 46 employees as of December 31, 2023. The number of employees increased by 3 or 6.98% compared to the previous year.
Employees
46
Change (1Y)
3
Growth (1Y)
6.98%
Revenue / Employee
$883
Profits / Employee
-$350,732
Market Cap
8.74M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
AIMD News
- 26 days ago - Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation - Accesswire
- 4 weeks ago - Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025 - Accesswire
- 5 weeks ago - Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule - Accesswire
- 5 weeks ago - Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled Robots - Accesswire
- 2 months ago - CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA - Accesswire
- 2 months ago - Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA - Accesswire
- 2 months ago - Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement - Accesswire
- 2 months ago - Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing - Accesswire